THE IDENTIFICATION AND SYSTEMATIZATION OF FINANCIAL ASSETS AND LIABILITIES, EXPOSED TO FINANCIAL RISKS, ON THE EXAMPLE OF THE PHARMACEUTICAL INDUSTRY
https://doi.org/10.26425/1816-4277-2019-6-134-142
Abstract
The best methods of identification of the financial assets and liabilities with highest risk concentration on the example of pharmaceutical companies have been considered. It is well known, that significant risks are subject to disclosure in financial statements of organization, because they can influence management decisions. It is important for professionals to understand how to correctly identify and assess the risks, influencing the financial statements, as well as to form a list of assets and liabilities, that are more affected by them. The above questions can be answered by the approaches presented in the article to the identification, assessment and systematization of risks, their impact on the financial statements, as well as the conclusions, formulated by the authors as a result of the research.
About the Authors
O. Ageeva
State University of Management
Russian Federation
Russian Federation
Ageeva Olga - Doctor of Economic Sciences.
Moscow.
A. Yolkina
State University of Management
Russian Federation
Russian Federation
Yolkina Anastasiya - Master of degree.
Moscow.
References
1. Ageeva O. A., Kardashov S. S. Problemy otrazheniya informatsii o finansovykh riskakh v finansovoi otchetnosti [Reflection problems of information on financial risks in the financial statements of companies]. Vestnik universiteta, 2011, I. 21, pp. 129-132.
2. Ageeva O. A., Kardashov S. S. Metodologicheskie osnovy modelirovaniya finansovogo riska investitsionnoe-stroitel’nykh kompanii [Methodological foundations of financial risk modeling investment and construction companies]. Finansy i uchet [Finance and Accounting], 2013, I. 1 (19), pp. 3-7.
3. Кryshkin О. Nastolnaya kniga po vnutrennemy auditu: riski i bisnes protsessy [Internal audit handbook: risks and business-processes], 5-e izd. М.: Alpina Publisher, 2018. 478 p.
4. Makeev R. Postanovka sistem vnutrennego kontrolya [Internal control system staging]. М.: Vershina, 2007. 296 p.
5. Pavlov М. I. Kak postroit’ effektivnuyu sistemu upravleniya riskami predpriyatiya [How to build an effective enterprise risk management system]. Aktsionernoe obschestvo: voprosy korporativnogo upravleniya [Joint-stock company: corporate governance issues], 2016, I. 11 (150). Available at: http://www.ao-journal.ru (accessed 03.03.2019).
6. Primery shablonov matritsy [Examples of risk matrix templates]. Portal resursov po upravleniyu riskami dlya malogo i srednego biznesa [Risk Management Resource Portal for Small and Medium Businesses]. Available at: www.risk-academy.ru (accessed 12.03.2019).
7. Tendentsii farmatsevticheskogo rynka Rossii – 2017 [Trends in the Russia Pharmaceutical Market – 2017]. Issledovatel’skii tsentr kompanii «Deloitte» v SNG [Deloitte Company Research Center in the CIS]. M., 2017. Available at: https://www2.deloitte.com (accessed 04.03.2019).
8. Federal’naya tselevaya programma «Razvitiye farmatsevticheskoi i meditsinskoi promyshlennosti Rossiiskoi Federatsii na period do 2020 goda i dal’neishuyu perspektivu» [Federal Target Program «Development of the pharmaceutical and medical industry of the Russian Federation for the period up to 2020 and beyond»]. Ofitsial’nyi sait Ministerstva ekonomicheskogo razvitiya [Official sait of the Ministry of Economic Development of Russian Federation]. Available at: http://economy.gov.ru (accessed 03.03.2019).
Review
For citations:
Ageeva O., Yolkina A. THE IDENTIFICATION AND SYSTEMATIZATION OF FINANCIAL ASSETS AND LIABILITIES, EXPOSED TO FINANCIAL RISKS, ON THE EXAMPLE OF THE PHARMACEUTICAL INDUSTRY. Vestnik Universiteta. 2019;(6):134-142. (In Russ.) https://doi.org/10.26425/1816-4277-2019-6-134-142
Views:
1194
Email this article 